Biocides

TrippBio announces publication of data supporting the antiviral potency of TD-213 against SARS-CoV-2

Retrieved on: 
Wednesday, May 26, 2021
Biocides, Sarbecovirus, Severe acute respiratory syndrome, Severe acute respiratory syndrome coronavirus, Antiviral drugs, Gilead Sciences

The manuscript entitled "Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro" describing the antiviral profile of TD-213 is available on an online preprint server at https://www.biorxiv.org/content/10.1101/2021.05.21.445119v1 is undergoing scientific peer-review for potential publication.

Key Points: 
  • The manuscript entitled "Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro" describing the antiviral profile of TD-213 is available on an online preprint server at https://www.biorxiv.org/content/10.1101/2021.05.21.445119v1 is undergoing scientific peer-review for potential publication.
  • These results will be used to design appropriate clinical trials to evaluate the efficacy of TD-213 as a treatment for mild-to-moderate COVID-19.
  • "We are pleased to finally be able to share these exciting data on the antiviral potency of TD-213 against the SARS-CoV-2 virus," said David E. Martin, PharmD, CEO.
  • We are currently planning our proof-of-concept study and look forward to reviewing the clinical data when available."

Food Sterilization Equipment Market by Application, Technology, Process and Geography - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 25, 2021
Retail, Restaurant, Bar, Food, Beverage, Chemistry, Physical sciences, Microbiology, Natural sciences, Biocides, Electron beam, Hygiene, Sterilization, Spice, Cobalt, Deactivation

The "Food Sterilization Equipment Market by Application, Technology, Process and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Food Sterilization Equipment Market by Application, Technology, Process and Geography - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • Food sterilization equipment helps to eliminate, remove, kills, or deactivates all forms of life and other biological agents from the food products.
  • The heat sterilization segment accounted for the largest market share of the global food sterilization equipment market in 2018.
  • The segment of 'spices, seasonings, & herbs' accounted for the largest share of the global food sterilization equipment market in 2018.

Global Pest Control Market (2020 to 2027) - by Type, Pest Type, Application and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, May 21, 2021
Other Construction & Property, Retail, Construction & Property, Other Retail, Insects in culture, Biocides, Pest control, Pesticide, Pest, Biological pest control, Termite, Physical sciences, Natural sciences, Organisms, Integrated pest management, Mating disruption

Pest control is the management of specific species of insects that are recognized as detrimental to human health.

Key Points: 
  • Pest control is the management of specific species of insects that are recognized as detrimental to human health.
  • This has resulted in increased demand for pest control management across the world.
  • However, health and environmental hazards caused by pesticides, due to their chemical content, is the significant factor anticipated to hamper the market growth during the forecast period.\nThe global pest control market is segmented on the basis of type, pest type, application, and region.
  • Depending on type, the market is categorized into chemical, mechanical, biological, and others.\nOn the basis of pest type, it is classified into insects, termites, rodents, and others.

Global Lifestyle Brand Executive Joins Ranger Ready Inc. Advisory Board

Retrieved on: 
Thursday, May 20, 2021
Household chemicals, Biocides, Home, Hiking equipment, Insect repellents, Hygiene, Chemical ecology, Permethrin, XC2, Ranger, Hand sanitizer

b"NORWALK, Conn., May 20, 2021 (GLOBE NEWSWIRE) -- Ranger Ready Inc., the parent company of Ranger Ready Repellents \xc2\xae, a premium tick and insect repellent brand, has appointed Curt Holtz to its Advisory Board that provides guidance as the company expands across channels and geographies.

Key Points: 
  • b"NORWALK, Conn., May 20, 2021 (GLOBE NEWSWIRE) -- Ranger Ready Inc., the parent company of Ranger Ready Repellents \xc2\xae, a premium tick and insect repellent brand, has appointed Curt Holtz to its Advisory Board that provides guidance as the company expands across channels and geographies.
  • Mr. Holtz has extensive experience as an outdoor apparel and footwear executive where digitally native lifestyle brands like Ranger Ready establish leadership.\nIn alignment with Ranger Ready\xe2\x80\x99s mission, Mr. Holtz asserts that it\xe2\x80\x99s imperative for strong brands to stand for something more than just sales.
  • \xe2\x80\x9cI'm excited to join the Advisory Board of Ranger Ready, as it grows in the important personal protection space,\xe2\x80\x9d said Mr. Holtz.
  • Premium products include Ranger Ready Picaridin 20% Body-Worn Repellents\xe2\x84\xa2\xef\xb8\x8f, Ranger Ready Permethrin 0.5%\xe2\x84\xa2\xef\xb8\x8f for clothing application, and Ranger Ready Hand Sanitizer \xe2\x84\xa2\xef\xb8\x8f, 80% alcohol topical hand sanitizer.\xc2\xa0 Ranger Ready is wholly owned by the PiC20 Group, LLC, a privately held company based in Norwalk, CT. Visit www.rangerready.com for more information.\n"

Recce Pharmaceuticals Announces Lead Synthetic Anti-infective RECCE® 327 Progresses to Stage 2 of SARS-CoV-2 Antiviral Screening Program at CSIRO

Retrieved on: 
Thursday, May 20, 2021
Antiviral drug, Biocides

b'SYDNEY, Australia, May 20, 2021 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (FSE:R9Q) (Company), the Company developing new classes of synthetic anti-infectives, today announced further results for the Company\xe2\x80\x99s synthetic anti-infective R327, as part of the SARS-CoV-2 Antiviral Screening Program (the Program).

Key Points: 
  • b'SYDNEY, Australia, May 20, 2021 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (FSE:R9Q) (Company), the Company developing new classes of synthetic anti-infectives, today announced further results for the Company\xe2\x80\x99s synthetic anti-infective R327, as part of the SARS-CoV-2 Antiviral Screening Program (the Program).
  • \xe2\x80\x9cWe are keen to continue our work with CSIRO in Stage 2 of the Anti-Viral Screening Program.\xe2\x80\x9d\nThe further Stage 1B testing which was highlighted as necessary in the Company\xe2\x80\x99s 12 February 2021 announcement has now been conducted by the Doherty Institute as part of the Program budget.
  • All intellectual property rights are retained by the Company with data to be reported as it becomes available.
  • Recce\xe2\x80\x99s anti-infective pipeline seeks to exploit the unique capabilities of RECCE\xc2\xae technologies targeting synergistic, unmet medical needs.\n'

Atea Pharmaceuticals Appoints Jerome Adams, M.D., M.P.H., to Board of Directors

Retrieved on: 
Thursday, May 20, 2021
Antiviral drug, Biocides

b'BOSTON, May 20, 2021 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe viral infections, today announced the appointment of Jerome Adams, M.D., M.P.H., to its Board of Directors.

Key Points: 
  • b'BOSTON, May 20, 2021 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe viral infections, today announced the appointment of Jerome Adams, M.D., M.P.H., to its Board of Directors.
  • With AT-527, Atea has the potential to bring an easily administered oral antiviral to help in the fight against this global public health crisis.
  • I am looking forward to lending my expertise to help advance this important program, while also supporting Atea in the development of its broader antiviral pipeline for severe viral diseases,\xe2\x80\x9d commented Dr. Adams.\nDr.
  • Before beginning his public service in 2014, Dr. Adams was a practicing anesthesiologist and Associate Professor in the Department of Anesthesiology at Indiana University.

Brilli Debuts World's First UV-Free Household Led Lighting Proven to Kill* Viruses and Bacteria

Retrieved on: 
Tuesday, May 18, 2021
Electromagnetic radiation, Electrodynamics, Radiation, Antimicrobial, Biocides, Ultraviolet, Bacteria, Microorganism, Mold

"\nNumerous studies have proven the effectiveness of Vyv\'s visible light against bacteria, mold, fungi, and yeast.

Key Points: 
  • "\nNumerous studies have proven the effectiveness of Vyv\'s visible light against bacteria, mold, fungi, and yeast.
  • The conclusive results prove that Brilli Bright Clean lighting powered by Vyv not only kills* but also prevents the growth of viruses, bacteria, fungi, mildew and mold on surfaces.
  • Unlike UV lights which are dangerous to humans, Brilli Bright Clean meets international standards for continuous and unlimited use around people, plants and pets.
  • Both the Brilli Bright Clean Antimicrobial 5/6" Recessed LED Fixture and Bright Clean Under Cabinet Antimicrobial LED Light Cleaning System are available on Amazon, Wayfair, Target and Home Depot.

Antimicrobial Coatings Market - Global Outlook and Forecast 2021-2026: Emergence Of New Technologies/ Innovation In Existing And New Products / High Demand For Controlling HAIs - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 18, 2021
Chemicals, Plastics, Manufacturing, Antimicrobial, Biocides

b'The "Antimicrobial Coatings Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global antimicrobial coatings market by revenue is expected to grow at a CAGR of approx.

Key Points: 
  • b'The "Antimicrobial Coatings Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global antimicrobial coatings market by revenue is expected to grow at a CAGR of approx.
  • The global silver material market expects to reach over USD 3 billion by 2026.\nSilver metals are heavily used in various end-user industries, which contribute over 54% of the market share by value.
  • China, India, and Japan are the key contributors to the APAC antimicrobial coatings market.
  • They expect to expand their presence worldwide during the forecast period, especially in the fast-developing countries in the APAC region, to gain more market share.\n'

Microban(r) Backs Antimicrobial Additives as a Scientifically Supported Strategy for Cleaner Building Materials

Retrieved on: 
Thursday, May 13, 2021
Antimicrobial, Biocides, Mildew

This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning.

Key Points: 
  • This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning.
  • Making a clear distinction between public health and non-public health claims, Microban has explained the advantages of incorporating its antimicrobial additives into building materials to protect articles from degradation by mold, mildew, and odor-causing microbes.
  • As demand for antimicrobial additives increases, this has never been more important.
  • Our proactive systems keep products cleaner, and control odors better by preventing problems before they start.

ILC Therapeutics Announces Board Changes and Funding Round to Accelerate Covid-19 Drug

Retrieved on: 
Thursday, May 13, 2021
Health, Infectious diseases, Research, Pharmaceutical, Science, Biotechnology, Medical specialties, Branches of biology, Medicine, Zoonoses, Immune system, Antiviral drug, Biocides, Virus, COVID-19, Interferon, Natural killer cell, Innate immune system

In some cases (SARS, MERS, Covid-19), viruses can evade the interferon response by delaying the innate immune response.

Key Points: 
  • In some cases (SARS, MERS, Covid-19), viruses can evade the interferon response by delaying the innate immune response.
  • A therapeutic like Alfacyte\xe2\x84\xa2 can offer enhanced interference to Covid-19 replication in the body and activate the body\xe2\x80\x99s own Natural Killer (NK) cells to fight virus infection.
  • Alfacyte\xe2\x84\xa2 has the potential to become an important antiviral treatment in the ongoing fight against RVI\xe2\x80\x99s in general and Covid-19 in particular.
  • It is also a vital treatment for those who are not able to take vaccines or choose not to.